Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Shares Plummet 9.3 Percent After Jury Sides With Third Wave in IP Suit

NEW YORK, Sept. 1 (GenomeWeb News) - Shares in Stratagene plummeted 9.3 percent and Third Wave Technologies' stock jumped 7.4 percent after Third Wave said it won its patent-infringement suit against Stratagene today.


As GenomeWeb News reported this morning, a jury has determined that Stratagene's quantitative PCR and RT-PCR reagents infringe two patents held by Third Wave Technologies as part of its Invader technology.


Stratagene's shares were down $.83 at $8.08 in mid-afternoon trading while Third Wave's shares were up $.38 at $5.52.


The jury, appointed by the United States District Court for the Western District of Wisconsin, found that certain embodiments of Stratagene's FullVelocity technology violate Third Weave's US patents Nos. 6,090,543 and 6,348,314. The jury will now hear arguments with respect to damages.


Third Wave filed the suit  last September. At the time, Stratagene said certain embodiments of its FullVelocity technology are not covered by Third Wave's patents.


In May, Stratagene countersued Third Wave claiming that Third Wave infringes patents that cover its FullVelocity technology. Stratagene's patents are USpatent Nos. 6,350,580; 6,528,254; 6,548,250; 6,589,743; and 6,893,819.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.